With a key FDA decision on its non-nicotine therapy cytisinicline expected by mid-2026, Achieve Life Sciences (ACHV) is drawing bullish attention for its potential to address a massive unmet need in smoking cessation and tap into a newly opened market void.
While Wall Street obsesses over GLP-1 weight-loss drugs, Novo Nordisk's foundational diabetes business continues to deliver robust growth and exceptional returns on assets, presenting a durable investment thesis often overshadowed by the obesity narrative.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Despite a recent rally, analysts argue Dollar General's defensive business model, deep rural footprint, and focus on essentials position it for steady, long-term growth as a haven for value-conscious investors.
AbbVie's $2.1 billion acquisition of Capstan Therapeutics signals a strategic pivot towards next-generation immunology treatments. The move aims to secure future revenue streams as the company navigates the post-Humira era, with analysts highlighting the transformative potential of its in vivo CAR-T platform.
For retirees, homeownership offers stability but also carries unique financial risks. Financial experts emphasize that a dedicated, liquid cash reserve for unexpected repairs is non-negotiable for protecting a fixed income.
Despite Adtalem Global Education posting robust quarterly results with 34% EPS growth, investment firm Peregrine Asset Advisers has liquidated its entire position, raising questions about the divergence between corporate performance and investor sentiment in the education sector.
Exclusive BBC analysis reveals nearly half of accredited zoos and aquariums in the UK and Ireland have sounded financial alarms since 2022, forcing tough choices between conservation missions and economic reality.
In an exclusive interview, GeneDx CEO Katherine Stueland details how rapid genomic testing is transforming pediatric care, slashing diagnosis times from years to days and building a data-driven bridge to future therapies.
Woodward (WWD) kicked off fiscal 2026 with robust earnings, driven by a surge in aerospace services and industrial sales. The company raised its full-year outlook but cautioned on supply chain pressures and announced a strategic wind-down of its volatile China On-Highway business.
Palantir Technologies' fourth-quarter earnings reveal a seismic shift, with U.S. commercial revenue for its AI Platform soaring 137%. The data analytics firm posted its highest growth rate as a public company, powered by massive government contracts and enterprise adoption, while setting aggressive targets for the year ahead.
As trillions pass to heirs, inheriting property often brings complex financial obligations, from taxes to upkeep, that can erode perceived wealth gains. Experts urge careful planning to navigate the emotional and fiscal challenges.
The U.S. dollar climbed to a one-week high, buoyed by unexpectedly strong manufacturing activity and hawkish-leaning Federal Reserve commentary. The rally pressured major currency pairs and sent precious metals tumbling, as markets reassessed the timeline for potential interest rate cuts.
As housing affordability hits historic lows, financial author JL Collins challenges a core tenet of the American Dream, arguing that homeownership can be a trap for capital and mobility, especially for those seeking early financial independence.
Shares of Huntington Bancshares (HBAN) have climbed over 17% in the past 90 days, closing recently at $17.88. This rally has investors scrutinizing whether the regional bank's stock still holds value after its strong run, with some models suggesting a significant upside to fair value.
A recent adjustment to Ceres Power Holdings' price target by analysts signals a broader reassessment of the clean energy firm's market narrative and future trajectory, moving beyond a single figure to underlying story shifts.
For the second consecutive year, a Chicago-based financial institution has become the nation's first bank to fail. Regulators shuttered Metropolitan Capital Bank & Trust on Friday, citing unsafe practices and depleted capital. The FDIC swiftly arranged for Detroit's First Independence Bank to assume most deposits and assets, ensuring customer funds remain secure.
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.
The reopening of Gaza's Rafah crossing for medical evacuations brought a glimmer of hope, but stringent Israeli restrictions limited departures to just five patients on the first day, leaving thousands in critical need still waiting.
A landmark lawsuit filed in Texas federal court targets a California physician for allegedly mailing abortion medication across state lines, testing a new state law that empowers private citizens to act as enforcers and setting up a clash with California's protective 'shield law'.
